Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Sep 1;18(9):e0291066. doi: 10.1371/journal.pone.0291066

Designing infographics in health research with patients and the public: A scoping review protocol

Blaze Beecher 1, Alan O’Doherty 1, Beatriz Goulao 2, Amirhossein Jalali 1,3, Jon Salsberg 1,3, Liz Dore 4, Ailish Hannigan 1,3,*
Editor: A K M Alamgir5
PMCID: PMC10473521  PMID: 37656722

Abstract

Information graphics or infographics combine visual representations of information or data with text. They have been used in health research to disseminate research findings, translate knowledge and address challenges in health communication to lay audiences. There is emerging evidence of the design of infographics with the involvement of patients and the public in health research. Approaches to involvement include public and patient involvement, patient engagement and participatory research approaches. To date, there has been no comprehensive review of the literature on the design of infographics with patients and the public in health research. This paper presents a protocol and methodological framework for a scoping review to identify and map the available evidence for the involvement of patients and the public in infographics design in health research. It has been informed by preliminary searches and discussions and will guide the conduct and reporting of this review.

Introduction

Information graphics or infographics combine visual representations of information or data with text “to communicate complex evidence-based information in an attractive and easily understandable way” [1]. Infographics can be static, animated or interactive and seek to educate, inform, or persuade the target audience [2]. In health research, they have been used to disseminate research findings, to translate knowledge and to increase health-promoting behaviours. Infographics may also address challenges in health communication to lay audiences with lower levels of health literacy or language barriers [3].

The G.R.A.P.H.I.C guidelines provide seven principles for the design of public health infographics, the first of which is to get to know your audience [4]. Scott et al. recommends getting advice from the target population group to ensure the infographic is appealing and understandable to them [5]. Piloting and evaluating the infographic on the target audience is recommended to verify that “the soul of the infographic” reaches them [6]. Given the central importance of the target population, design strategies for infographics which actively involve patients and the public may be useful. Approaches to involvement include public and patient involvement, patient engagement and participatory research approaches (see Table 1 for definitions).

Table 1. Terminology and definitions.

Terminology Definition
Public and Patient Involvement “Research being carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them.” [10]
Patient Engagement “The active, meaningful, and collaborative interaction between patients and researchers across all stages of the research process, where research decision making is guided by patients’ contributions as partners, recognizing their specific experiences, values, and expertise.” [11]
Co-production “An approach in which researchers, practitioners and the public work together, sharing power and responsibility from the start to the end of the project, including the generation of knowledge.” [12]
Participatory Health Research “The goal of Participatory Health Research is to maximize the participation of those whose life or work is the subject of the research in all stages of the research process.” [13]

There is emerging evidence of the design of infographics with the involvement of patients and the public in health research. Arcia et al. used iterative participatory co-design sessions with Hispanic family caregivers of people with dementia to identify which infographic prototypes supported caregivers’ comprehension of health status [7]. Staatz et al. used a public and patient involvement approach with pregnant women to develop an infographic to promote a healthy diet during pregnancy, providing the women with the choice of two aesthetically different options and getting input on their design, content, missing information and ease of understanding [8]. Campbell et al. used patient engagement techniques with children who had experienced a concussion and their parents to develop, refine and evaluate the usability of an education infographic on paediatric concussion [9].

To date, there has been no comprehensive review of the literature on the design of infographics with patients and the public in health research. The objective of this scoping review is to address this gap by identifying and mapping the available literature. Scoping reviews are useful for mapping an emerging body of literature by methods used, key concepts and characteristics, and types of evidence [14]. They often identify a broader range of evidence, acting as a precursor for systematic reviews and can also identify knowledge gaps [14, 15]. This protocol outlines the steps we will use to carry out this review, informed by best practice guidance and reporting for the development of scoping review protocols [15].

Materials and methods

This protocol has been reported using the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for systematic review protocols (PRISMA-P) [16] S1 Checklist.

Methodological framework

This scoping review will use Arksey and O’Malley’s methodological framework [17], adapted by Levac et al. [18], with six stages: (i) Identifying the research question; (ii) Identifying relevant studies; (iii) Study selection; (iv) Charting the data; (v) Collating, summarising, and reporting results; and (vi) Consultation. The results of the review will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews (PRISMA-ScR) [19].

Stage 1: Identifying the research question

We used the Population Concept Context framework to develop our review question. The population is patients and the public, the concept is designing infographics and the context is health research. Our review question is ‘How have patients and the public been involved in designing infographics in health research?’

Stage 2: Identifying relevant studies

Eligibility criteria

Population. All studies with patients and the public are eligible for inclusion without restriction on demographics or diagnosis. Studies with non-human participants will be excluded. Studies with patients and the public, together with other participants e.g. researchers, healthcare practitioners or healthcare students, will be included only if the data for patients and the public can be disaggregated from the results.

Concept. All studies which use approaches for involvement (participatory, public and patient involvement, patient engagement) to develop an infographic will be included. This will include, for example, co-design with patients and the public; usability and comprehension testing; evaluation of acceptability and satisfaction; and feedback on content and presentation format by patients and the public. Our focus is specifically on infographics, excluding video assisted education and visual narratives. Studies without any approaches for involvement and without the development of an infographic will be excluded.

Context. All health research studies are eligible for inclusion without restriction on health topic, study design, setting (e.g. community, healthcare) or geographical location. A broad definition of health will be used to encompass physical, mental and social well-being [20]. Studies without a focus on health will be excluded.

Types of sources. All study designs (quantitative, qualitative, and mixed methods) will be included. Reviews of the literature will be included. Primary sources will be excluded if the data they contain have already been incorporated in an included review of the literature. Peer-reviewed and grey literature (conference proceedings, theses, reports) published in English (the language of the reviewers) with no date restriction are included. Protocols will be excluded.

Comprehensive searches will be carried out in the following databases: Scopus, PubMed Central, Web of Science Core Collection, EMBASE, CINAHL Complete, PsychINFO, Cochrane Library and ProQuest Dissertations and Theses. Google Scholar will be used for searching for relevant grey literature. Reference lists of all included studies will be screened for any additional relevant studies. Key authors will be contacted to provide potentially relevant studies for review.

Examples of preliminary database searches conducted in Web of Science and Scopus are given in Table 2 using title, abstract, and keywords fields. The search strategy will be adapted for each database and further refined in consultation with a research librarian. Any changes to the strategy will be documented and reported. All searches will be conducted after approval of the protocol.

Table 2. Examples of preliminary database searches.
Database: Web of Science Core Collection (searching ‘topic’ field: title, abstract, author keywords, and Keywords Plus).
Date: 13/04/23
Infographic* AND (involve* OR participat* OR engag* or co-creat* OR co-design*) AND (patient OR public OR consumer) (Topic) and English (Languages)
Results: 143 documents
Database: Scopus
Date 13/04/23
( TITLE-ABS-KEY ( infographic* ) AND TITLE-ABS-KEY (involve* OR participat* OR engag* or co-creat* OR co-design*) AND TITLE-ABS-KEY (patient OR public OR consumer ) ) AND ( LIMIT-TO ( LANGUAGE , "English" ) ) 
Results: 193 documents

Stage 3: Study selection

Citations identified in the search will be compiled and exported to Endnote 20 (Clarivate Analytics, PA, USA) bibliographic software. Duplicates will be removed. Citations will be imported into Covidence systematic review software (Veritas Health Innovation) for title and abstract screening. The screening process will be independently piloted by two reviewers on a subset of 50 citations and then all citations will be screened, by title and abstract, using the inclusion and exclusion criteria. Full-texts of potentially relevant citations will be sourced and reviewed by two independent reviewers with disagreement resolved by discussion or by a third reviewer. Reasons for exclusion at full-text review will be documented. The results of the identification, screening, eligibility and inclusion of citations will be presented in a PRISMA-ScR flow diagram [19].

Stage 4: Charting the data

The data extracted from each publication will include general information on the publication (e.g. authors, year of publication), details about the study (e.g. methods, location), details on the population, concept, context, and key findings relevant to the review. A draft data extraction tool is given in Table 3. This will be piloted by two independent reviewers on a subset of 10 included publications. The draft tool will be adapted as needed during the data extraction process, in discussion with the two independent reviewers and a third reviewer if needed. Any changes to the tool will be documented and reported. Authors of publications will be contacted if all data to be extracted is not available in the published paper.

Table 3. Draft data extraction tool.

Categories Questions
Publication Details
Author(s) Who are the authors of the publication?
Year of Publication When was it published?
Country of origin Where was the study carried out?
Publication Type Is the publication a journal article, conference proceeding, thesis, report, other?
General Overview of Study
Objective and aims What was the objective and aims of the study?
Methods What methods (e.g. qualitative, quantitative, mixed methods) were used to design/evaluate the infographic?
What methods were used for involvement of patients and the public in the design process?
Population Who were the participants e.g. how were they recruited, number of participants and their demographics?
Concept What was the purpose of the infographic e.g. to education, inform, persuade?
How was involvement defined?
What was the role of the participants e.g. choosing between prototypes, deciding on content, assessing understanding, interpreting data, as co-authors?
Context What was the health topic?
Who did the infographic target and in what setting e.g. community, healthcare?
Findings/results Was the infographic evaluated and if so, how?
What were the outcomes?
Was the role of patients and the public evaluated and if so, how?
What changes were made to the infographic as a result of the involvement of patients and the public?
Any challenges/limitations reported?

Stage 5: Collating, summarising and reporting the results

Scoping reviews, unlike systematic reviews, do not typically assess methodological quality or risk of bias of included studies or conduct data synthesis e.g. a meta-analysis [15]. Instead, a descriptive summary of included studies is provided. We will numerically and narratively summarise year of publication, geographical location, setting, study design, health topic, and purpose of the infographic in included studies. This will be used to report the most common areas of application of involvement, whether there is evidence of increasing use of involvement of patients and the public over time and whether it is more common for particular study designs and countries. A descriptive numerical summary of the number of participants and their demographics will also be conducted to identify the range and typical number of participants and common characteristics. In addition, a narrative summary of the process and evaluation of designing infographics will be used to answer the review question on how patients and the public have been involved. Outcomes of the evaluation of the infographic will be reported and summarised. Findings will be organised into thematic categories relating to types of studies, process and evaluation of involvement, and research gaps.

Stage 6: Consultation

As recommended by Levac et al., we will include consultation as a necessary component of the proposed scoping review [18]. We will use the consultation stage to gain new perspectives on and meaning of preliminary findings, discuss potential for application and dissemination of findings and identify areas for future research. We plan consultation with the Public and Patient Involvement Research Unit, a multidisciplinary unit in the University of Limerick with collaborative partnerships with community organisations, academia, health service providers and policy makers to build evidence about meaningful public and patient involvement.

Discussion

This protocol outlines the methodological framework and process we will use to identify and map the available evidence on the involvement of patients and the public in the design of infographics in health research. It has been informed by discussion and preliminary searches and will be used to guide the conduct and reporting of this review. Publishing a review protocol can reduce research waste, increase transparency and avoid selective reporting of results [15]. It also provides an opportunity for feedback from the research community in advance of the review which can provide valuable input to inform its conduct.

Supporting information

S1 Checklist. PRISMA-P checklist.

(DOCX)

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The authors received no specific funding for this research.

References

  • 1.Mc Sween-Cadieux E, Chabot C, Fillol A, Saha T, Dagenais C. Use of infographics as a health-related knowledge translation tool: protocol for a scoping review. BMJ open. 2021; 11(6):e046117. doi: 10.1136/bmjopen-2020-046117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Otten JJ, Cheng K, Drewnowski A. Infographics And Public Policy: Using Data Visualization To Convey Complex Information. Health Affairs. 2015;34(11):1901–7. doi: 10.1377/hlthaff.2015.0642 [DOI] [PubMed] [Google Scholar]
  • 3.Arcia A, Suero-Tejeda N, Bales ME, Merrill JA, Yoon S, Woollen J, et al. Sometimes more is more: iterative participatory design of infographics for engagement of community members with varying levels of health literacy. Journal of the American Medical Informatics Association. 2015;23(1):174–83. doi: 10.1093/jamia/ocv079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Stones C, Gent M. The 7 graphic principles of public health infographic design. Leeds: University of Leeds. 2015. [Google Scholar]
  • 5.Scott H, Fawkner S, Oliver CW, Murray A. How to make an engaging infographic?. British Journal of Sports Medicine. 2017;51(16):1183–4. doi: 10.1136/bjsports-2016-097023 [DOI] [PubMed] [Google Scholar]
  • 6.Hernandez-Sanchez S, Moreno-Perez V, Garcia-Campos J, Marco-Lledó J, Navarrete-Muñoz EM, Lozano-Quijada C. Twelve tips to make successful medical infographics. Medical Teacher. 2021;43(12):1353–9. doi: 10.1080/0142159X.2020.1855323 [DOI] [PubMed] [Google Scholar]
  • 7.Arcia A, Suero-Tejeda N, Spiegel-Gotsch N, Luchsinger JA, Mittelman M, Bakken S. Helping Hispanic Family Caregivers of Persons With Dementia “Get the Picture” About Health Status Through Tailored Infographics. The Gerontologist. 2019;59(5):e479–e89. doi: 10.1093/geront/gnz085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Staatz CB, Llewellyn C, Smith A, Croker H. Reducing excessive maternal weight gain: use of public and patient involvement to inform development of an infographic to promote healthy eating during pregnancy. The Lancet. 2018. Nov 1;392:S82. 10.1016/S0140-6736(18)32922-2. [DOI] [Google Scholar]
  • 9.Campbell A, Hartling L, Plourde V, Scott SD. Parental Knowledge, Self-confidence, and Usability Evaluation of a Web-Based Infographic for Pediatric Concussion: Multimethod Study. JMIR Pediatr Parent. 2022;5(2):e36317. doi: 10.2196/36317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.10.2196/36317 INVOLVE. Public involvement in research: Values and principles framework. Eastleigh, UK: Nihr Involve. (2015). https://www.invo.org.uk/wp-content/uploads/2017/08/Values-Principles-framework-Jan2016.pdf. [DOI] [Google Scholar]
  • 11.Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, et al. Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group. Value Health. 2020;23(6):677–88. doi: 10.1016/j.jval.2020.01.019 [DOI] [PubMed] [Google Scholar]
  • 12.NIHR (2021) Guidance on co-producing a research project. https://www.invo.org.uk/wp-content/uploads/2019/04/Copro_Guidance_Feb19.pdf. [Google Scholar]
  • 13.International Collaboration for Participatory Health Research, Position Paper No. 1 (2013). http://www.icphr.org/uploads/2/0/3/9/20399575/ichpr_position_paper_1_defintion_-_version_may_2013.pdf. [Google Scholar]
  • 14.Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC medical research methodology. 2018. Dec;18:1–7. 10.1186/s12874-018-0611-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953–68. doi: 10.11124/JBIES-21-00242 [DOI] [PubMed] [Google Scholar]
  • 16.Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Systematic Review. 2015;4(1):1. doi: 10.1186/2046-4053-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19–32. 10.1080/1364557032000119616. [DOI] [Google Scholar]
  • 18.Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implementation Science. 2010;5(1):69. doi: 10.1186/1748-5908-5-69 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73. doi: 10.7326/M18-0850 [DOI] [PubMed] [Google Scholar]
  • 20.Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York: World Health Organization, 19–22 June, 1946. Available from: https://www.who.int/about/governance/constitution. [Google Scholar]

Decision Letter 0

AKM Alamgir

22 Aug 2023

Designing infographics in health research with patients and the public: a scoping review protocol

PONE-D-23-18262

Dear Dr. Ailish Hannigan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and is formally accepted for publication .

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

AKM Alamgir, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. Thank you for stating the following financial disclosure: 

"The authors received no specific funding for this research."

e) Please provide an amended Funding Statement that declares *all* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  

f) Please state what role the funders took in the study.  If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

Please send your amended statements by return email; we will change the online submission form on your behalf. 

Academic Editor's comments: The reviewers recommended this article to publish in our journal.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review your protocol As someone interested and invested in creating good quality co-created infographics I found this really interesting.

This seems to me to be a well constructed scoping review protocol focusing on a topic of interest and worth publishing.

A couple of points (and apologies if I have missed your mention of these). These are points that could be addressed.

You note in the introduction that the GRAPHIC guidelines provide seven principles.... but then don't mention them again. Are these embedded in someway in your data extraction sheet? It might be worth mentioning this.

Also, it may be that you intend to do this and I'be not properly noticed this in the data extraction sheet/protocol but will you be looking at the actual infographics yourself?

Also will you be reporting on the type of infographic (paper, electronic, static/animated etc.)?

Reviewer #2: The scoping review protocol is described in a clear and easy to follow format. I would be interested in seeing if you have done a pilot using this review methodology and if so were there any changes / adaptations made after this?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bernie Carter

Reviewer #2: No

**********

Acceptance letter

AKM Alamgir

25 Aug 2023

PONE-D-23-18262

Designing infographics in health research with patients and the public: a scoping review protocol

Dear Dr. Hannigan:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr AKM Alamgir

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA-P checklist.

    (DOCX)

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES